for circulating plasminogen, is thought to minimise the systemic thrombolytic effects of tissue plasminogen activator.
Bleeding may be reduced by the regional application of tissue plasminogen activator directly onto the clot with the assumption that the thrombolytic effect will be entirely local. This is attractive for clots associated with indwelling intravascular catheters which may be used as the treatment route.
Our two patients received a low dose infusion of tissue plasminogen activator as a regional application to try to achieve clot lysis with minimal systemic effects.
A similar low dose (005 mg/kg/hour) regional infusion of tissue plasminogen activator has been used in four neonates with caval thrombosis secondary to indwelling intravascular catheters. 2 There was successful lysis of the clot in three of the patients. In one patient the infusion caused a decrease in fibrinogen concentrations and an increase in fibrin degradation products and this infant had an intraventricular haemorrhage.
When higher doses of tissue plasminogen activator (O -1-0-5 mg/kg/hour) were given to 12 children,3 six had bleeding complications. In these six patients bleeding was associated with a tissue plasminogen activator dose of 046-0 50 mg/kg/hour).
The age of the clot to be lysed has an important effect on its susceptibility to thrombolysis. Most HHV-6 and herpes simplex virus DNA were extracted from the cerebrospinal fluid and amplified by the nested polymerase chain reaction (PCR) using procedures reported elsewhere.4 antigen in the brain tissue was examined by enzyme immunoassay using monoclonal antibodies to HHV-6 as described elsewhere.5 Results HHV-6 was isolated from blood obtained on day 1 of the illness, but not from blood on days 5 and 18. HHV-6 DNA sequences were detected in the cerebrospinal fluid obtained on day 1 of the illness by the PCR. There was a significant rise in the antibody titres to HHV-6 from day 1 (<4) to day 5 It is generally believed that exanthem subitum is a common benign infectious disease and the prognosis is uniformly excellent even for cases complicated by convulsive seizures. However, although the case reported here is a rare complication of exanthem subitum, it is important for physicians who care for patients with exanthem subitum to be aware of the potential hazard of unexpected death.
human herpesvirus-6 infection. 
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